Vaccine Adjuvants Market and the Increasing Use in Vaccine


Posted May 11, 2020 by healthcaremarket

The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%.
 
The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%. The global market is broadly classified into product type, route of administration, disease type, applications, and application categories.

Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021

Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152603894

On the basis of route of administration, the market is segmented into oral, subcutaneous, intranasal, intramuscular, intradermal, and others. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. Factors such as the rapidly growing geriatric population and vaccines for improved immunization are propelling the growth of this market.

On the basis of disease type, the vaccine adjuvants market is segmented into infectious diseases, cancer, and others. The infectious diseases segment is expected to account for the largest share of the global market in 2016. Factors such as high prevalence of infectious diseases, government & company initiatives, and high prevalence of cancer cases are expected to drive market growth in the coming years.

Request for Sample Pages @https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894

Key Market Players

The major players in the vaccine adjuvants market are Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).

Target Audience for this Report:

⏩ Vaccine adjuvants manufacturers and suppliers
⏩ Academic research institutes
⏩ Biopharmaceutical and biotechnology companies
⏩ Research and development (R&D) companies
⏩ Business research and consulting service providers
⏩ Medical research laboratories
⏩ Academic medical centers and universities

Get More Information @https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=152603894
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By marketsandmarkets
Phone 08886006441
Country United States
Categories Government , Health , Medical
Tags adjuvants ppt , immunologic adjuvant , vaccine adjuvants market , vaccine adjuvants review , vaccine adjuvants wiki
Last Updated May 11, 2020